Close

Zuellig pharma collaborates with Taiko on Cleverin in Taiwan

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Fluid Path Integrity: Ensuring Purity in Biomanufacturing

In the high-stakes arena of biomanufacturing, where tiny contaminants...

GMP Fluid Handling: Regulatory Compliance Explained

Fluid Handling in GMP Manufacturing: The Essence of Regulatory...

Single-Use Technologies in Biopharma Transform Manufacturing

The biopharmaceutical sector is being revolutionized by the demand...

Advances in Aseptic fluid transfer solutions

Sterility and Cross-Contamination: The Cornerstones of Modern Biopharma Manufacturing Biopharmaceutical...

Building on many years of partnership, Zuellig Pharma Taiwan and Taiko Pharmaceutical Limited have kicked off a new collaboration that will see Zuellig Pharma distribute and promote Cleverin in Taiwan. 

 

Cleverin® is a leading Japanese environmental decontamination technology, and has been listed by the US Centers for Disease Control and Prevention and Occupational Safety and Health Administration as an effective disinfectant for healthcare organization and household use. The brand sells approximately 10 million bottles in Japan every year. 

Zuellig Pharma Taiwan Chief Executive John Chou said: “Cleverin® is an innovative environmental decontaminant technology to prevent infectants spreading at home. We are proud to work with Taiko Pharmaceutical to help them make this technology available in the Taiwan market.” As part of the promotional strategy, Zuellig Pharma Taiwan organized for Taiko Pharmaceutical President Dr. Takashi Shibata to give a presentation at the Greater Taipei Area Hospital and the Densely Populated Organization Infection Control Seminar. 

“Dr. Shibata was invited to speak as an expert in chlorine dioxide gas technology and the experience the company has had in Japan with this technology,” Mr. Chou said. “The events were attended by Minister of Health and Welfare Dr. Lin Tzou-yien, and more than 800 healthcare professionals. It was therefore a great opportunity for us to raise awareness of Taiko Pharmaceutical and its expertise in this category among Taiwan’s medical community.”

Latest stories